34 22 With the effective treatment of wounds from sores to lacerations, Pathelen Health Care is the company behind the Pathelen Hybrid medical device, a treatment that focuses on encouraging the healing process. It does this by ensuring that any biofilms that prevent the formation of new tissue are removed, reducing the risk of infection and increasing the effectiveness of the body’s ability to recover from the wound. All of this, as well as its client service abilities, has earned it the title of ‘2022’s Most Innovative Biotech Company’ in Switzerland & 2022’s Awards for Excellence in Innovation. The Wound Closure Solution of the Future ith a core flagship product around which everything else has been created, Pathelen Health Care’s focus has been on its Pathelen Hybrid since its inception. Nominally, Pathelen Hybrid is a medical device that has been registered with SwissMedic and the USA FDA as an exemplary device for use in non-healing chronic wounds. Built to stimulate the healing time of such wounds as diabetic foot ulcers, ulcus cruris, and bed sores, the Pathelen Hybrid has its uses in ensuring that potentially damaging wounds are taken care of in a way that avoids the condition of the body worsening. In this way, use of the device has prevented amputation by ensuring the wounds are taken care of in a timely manner. Critically, as a superabsorber, this product’s main draw is its ability to deal with any discharged liquid that a wound creates, making sure that it doesn’t linger around the sore and cause increased danger of infection or sepsis. Hygienic, utilitarian, and safe to use, it ensures that every medical professional who comes into possession of the device knows how to use it, but has also worked hard to ensure that the device is not overly complicated in any way, shape or form. In healthcare – especially when dealing with open wounds – time is often of the essence, especially when amputation is at stake; thus, it has strived to cut the fat from the process. Specifically, its main target is the removal of biofilms that prevent the formation of granulation tissue. First and foremost, the prevention of granulation tissue is what prevents a wound from closing and can mean additional danger for a patient in terms of the wound getting worse, making it a longer and more painful healing process. Thus, the superabsorbent properties of Pathelen Hybrid take the uncertainty out of it, ensuring that biofilms are kept to a minimum after its application once the wound is clean of debris. Granulation tissue is normally formed after 3-5 days, which leads to a successful complete closure between 3 and 8 weeks depending on the size and severity of the laceration or sore. Moreover, with a success far above the norm for medical devices of its kind, it has gone above and beyond the expectations of the medical community for it at every turn, with no side effects observed and no added complications thanks to the use of the Pathelen hybrid device. Instead, patients it has been used on have reported back with successful wound closures within the forecasted time and a good experience with it that has allowed it to become a staple of the hospitals and medical facilities it has provided its medical devices to. In this manner, it has been able to achieve its goals through its own innovations, developments, and tenacity, something that it will be continuing to do long into the future. This dedication to constant improvement has vastly further endeared it to the medical industry and the international medical community, as the smallest change in variable could be the difference between a patient keeping a limb and losing it. If the Pathelen Hybrid is applied within a timely manner, its usefulness in saving life and limb truly cannot be overstated. Going forward, Pathelen looks forward to continuing to improve W “Built to stimulate the healing time of such wounds as diabetic foot ulcers, ulcus cruris, and bed sores, the Pathelen Hybrid has its uses in ensuring that potentially damaging wounds are taken care of in a way that avoids the condition of the body worsening. In this way, use of the device has prevented amputation by ensuring the wounds are taken care of in a timely manner.” Mar22632 AG
RkJQdWJsaXNoZXIy MTQxNTg3MQ==